Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study

NCT05554822 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

574

Enrollment

OTHER

Sponsor class

Conditions

Left Atrial Appendage Occlusion
Antiplatelet Therapy

Interventions

DRUG: Aspirin 100mg
DRUG: Aspirin 100 mg OD plus clopidogrel 75 mg OD

Sponsor

Azienda Ospedaliero Universitaria Maggiore della Carita

Collaborators

[object Object]